multiple sclerosis
TRENTON, N.J. (AP) — U.S. regulators have approved the first drug for an aggressive kind of multiple sclerosis that steadily reduces coordination and the ability to walk. The Food and Drug Administration approved Ocrevus late Tuesday after a large study found it slowed progression of the neurological disease and reduced symptoms. While there are more […]
Trending
On Air
-
Mushroom Mania: 2022’s Trendy Plant Boasts Major Health Benefits
-
Dr. James Taylor l The Carl Nelson Show
-
WATCH: What You Need To Know — January 12, 2022: Biden’s True Test — RNC Pays Trump Bills — Black and Missing
-
WATCH: What You Need To Know — November 13, 2020: Biden Gaining Acceptance — Sterling Brown Settles $750K Lawsuit — New Obama Memoir